Navigation Links
Vanda Pharmaceuticals to Announce Third Quarter 2013 Financial Results on November 7, 2013
Date:10/21/2013

WASHINGTON, Oct. 21, 2013 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders, today announced it will release results for the third quarter of 2013 on Thursday, November 7, 2013, before the market opens.

The Company will host a conference call at 10:00 AM ET on Thursday, November 7, 2013, during which Vanda management will discuss the financial results.  To participate in the conference call, please dial 1-888-895-5271 (domestic) or 1-847-619-6547 (international) and use passcode 35919679.

The conference call will be broadcast simultaneously and archived on the Company's website, www.vandapharma.com.  Investors should go to the website at least 15 minutes early to register, download, and install any necessary audio software.

A replay of the call will be available on Thursday, November 7, 2013, beginning at 12:00 PM ET and will be accessible until Thursday, November 14, 2013, at 5:00 PM ET.  The replay call-in number is 1-888-843-7419 for domestic callers and 1-630-652-3042 for international callers.  The passcode number is 35919679.

ABOUT VANDA PHARMACEUTICALS INC.:    
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders.  For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com.  

Investor Contact:   
Chad Rubin
Vice President
The Trout Group
(646) 378-2947
crubin@tro
'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Vanda Pharmaceuticals Inc. Proposes Public Offering of Common Stock
2. UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors with Losses on Their Investment in Vanda Pharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of August 24, 2013 to Seek a Lead Plaintiff Position
3. Vanda Pharmaceuticals Reports Second Quarter 2013 Results
4. Vanda Pharmaceuticals to Announce Second Quarter 2013 Financial Results on July 31, 2013
5. Vanda Pharmaceuticals to Participate in Upcoming Investor Conferences
6. Vanda Pharmaceuticals, Inc. Sued by Investor
7. Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder
8. Vanda Presents Data From Tasimelteon Phase III Studies In Non-24-Hour Disorder
9. Vanda Pharmaceuticals to Present at the Jefferies 2013 Global Healthcare Conference
10. Vanda Announces Submission To FDA Of A New Drug Application For Tasimelteon For The Treatment Of Non-24-Hour Disorder In The Totally Blind
11. Vanda to Present Tasimelteon Non-24 Phase III Data at Two Medical Meetings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... 29, 2014 According to a ... Navigation Systems Market (Neurosurgical Navigation Systems, ENT Navigation Systems ... Share, Growth, Trends and Forecast, 2014 - 2020", the ... 218.5 million in 2013 and is expected to grow ... to reach an estimated value of USD 295.5 million ...
(Date:7/29/2014)... NEW YORK , July 29, 2014 /PRNewswire/ ... team of Caremark Rx, Drew Crawford today ... PBM365 is the leading independent media source dedicated to ... and opinion on the pharmacy benefit management (PBM) industry ... timely coverage of, and context behind, industry news.   The ...
(Date:7/29/2014)... July 29, 2014 According to ... "Orthopedic Trauma Fixation Devices Market - Global Forecast, Market ... the global orthopedic trauma fixation devices market is estimated ... to grow at a CAGR of 7.2% from 2014 ... 9.3 billion in 2020. Browse the Orthopedic ...
Breaking Medicine Technology:Surgical Navigation Systems Market Expected to Reach USD 295.5 Million Globally in 2020: Transparency Market Research 2Surgical Navigation Systems Market Expected to Reach USD 295.5 Million Globally in 2020: Transparency Market Research 3Surgical Navigation Systems Market Expected to Reach USD 295.5 Million Globally in 2020: Transparency Market Research 4Drew Crawford Announces Launch of PBM365 Media 2Orthopedic Trauma Fixation Devices Market is Expected to Reach USD 9.3 Billion Globally in 2020: Transparency Market Research 2Orthopedic Trauma Fixation Devices Market is Expected to Reach USD 9.3 Billion Globally in 2020: Transparency Market Research 3Orthopedic Trauma Fixation Devices Market is Expected to Reach USD 9.3 Billion Globally in 2020: Transparency Market Research 4
... SOUTH SAN FRANCISCO, Calif., Nov. 3 Rigel Pharmaceuticals, Inc. ... third quarter and nine months ended September 30, 2009. , ... loss of $26.7 million, or $0.70 per share, compared to ... in the third quarter of 2008. Weighted average shares outstanding ...
... Calif., Nov. 3 Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ... will present a company overview at Canaccord Adams, 2009 Cardiovascular ... at the Nikko Hotel in San Francisco. , A live ... "Investors & Media" section of the Company,s Web site, ...
Cached Medicine Technology:Rigel Announces Third Quarter 2009 Financial Results 2Rigel Announces Third Quarter 2009 Financial Results 3Rigel Announces Third Quarter 2009 Financial Results 4Rigel Announces Third Quarter 2009 Financial Results 5
(Date:7/29/2014)... 29, 2014 New high priced hepatitis ... D by a projected $2.9 to $5.8 billion next ... firm Milliman released today by the Pharmaceutical Care Management ... could increase by as much as 8.6 percent in ... including Sovaldi and Olysio. , The study finds that ...
(Date:7/29/2014)... The Law Offices of Michael Cordova is ... a non-profit organization providing grief camps for kids, teens, adults, ... suffering our clients experience from the death of a loved ... organization like Stepping Stones of Hope, as they provide hope ... of Hope also includes a monthly support group and a ...
(Date:7/29/2014)... record the severity and regularity of their pain is ... , A new approach to the treatment of headaches, ... and is being led by Professor Paul Martin from ... He has developed an approach designed to enable people ... Learning to Cope with Triggers (LCT). , Using a ...
(Date:7/29/2014)... cases of cancer is to surgically remove the tumor. ... the surgeon may fail to extract the entire tumor, ... technique, researchers at the University of Pennsylvania have established ... tumor in the patient, increasing the likelihood of a ... that accumulates in cancerous tissues much more so than ...
(Date:7/29/2014)... A new 3-part video series: The Cost/Benefit ... Cardiovascular Angiography and Interventions (SCAI) Scientific Sessions in Las ... review the benefits of ACE accreditation and the cost/benefit ... laboratory from the perspective of clinicians who have worked ... MS, RN, Director of Cardiac and Interventional Services at ...
Breaking Medicine News(10 mins):Health News:New Milliman Study: Hepatitis C Drugs Could Increase Medicare Part D Spending by $2.9 to $5.8 Billion in 2015 2Health News:The Law Offices of Michael Cordova is Sponsoring Stepping Stones of Hope, a Non-Profit Organization Providing Grief Camps for Kids, Teens, Adults, and Families 2Health News:Penn team makes cancer glow to improve surgical outcomes 2Health News:Penn team makes cancer glow to improve surgical outcomes 3Health News:Accreditation for Cardiovascular Excellence (ACE) Launches 3-Part Video Series: The Cost/Benefit of ACE Accreditation; ProMedica Toledo Hospital Achieves Accreditation 2Health News:Accreditation for Cardiovascular Excellence (ACE) Launches 3-Part Video Series: The Cost/Benefit of ACE Accreditation; ProMedica Toledo Hospital Achieves Accreditation 3
... ... hand, the first product from its new upper extremity range, bebionic. Launched at the ISPO ... worldwide, at a cost of approximately 9,000 Euros, or $11,000 USD. , ... (PRWeb UK) July 1, 2010 -- RSLSteeper have ...
... ... manufacturing techniques that provide a higher quality, more fashionable product. Overcoming the knitting machine ... , ... 2010 --When seeking a non-binding top or diabetic sock you want comfort, but ...
... ... based provider of the Erec-Tech vacuum therapy system for the treatment of ... score of 96. As the leader in the field of vacuum therapy ... these current economic times and when Medicare dollars are scarce. You ...
... PICK: Identifying preterm infants at risk of life-threatening conditions ... to life-threatening conditions that are clinically difficult to detect. ... microbes are present in the blood, and necrotizing enterocolitis, ... But now, Terrence Poon and colleagues, at the The ...
... have enticed scientists because of the potential to provide more ... tumor,s most voracious cells. Now, researchers at Children,s Hospital Boston ... model of the most common form of human lung cancer ... may vary from tumor to tumor, depending upon the tumor,s ...
... By Jenifer Goodwin HealthDay Reporter , THURSDAY, July ... and CSI may not be good for seniors, mental ... Americans ages 15 to 98 and found that adults over age ... TV than younger adults. But while the younger ...
Cached Medicine News:Health News:RSLSteeper announces pricing for new bionic hand 2Health News:Diabetic Sock Manufacturing Techniques Improved 2Health News:Stamen Medical Systems Receives Medicare Re-Accreditation and The Exemplary Provider Award 2Health News:JCI online early table of contents: July 1, 2010 2Health News:JCI online early table of contents: July 1, 2010 3Health News:JCI online early table of contents: July 1, 2010 4Health News:JCI online early table of contents: July 1, 2010 5Health News:JCI online early table of contents: July 1, 2010 6Health News:JCI online early table of contents: July 1, 2010 7Health News:Cancer stem cells are not 1 size fits all, lung cancer models show 2Health News:Older Folks Watch More TV, Get Less Out of It 2Health News:Older Folks Watch More TV, Get Less Out of It 3
To maintain the conjunctival cul-de-sacs after enucleation or evisceration without hindering lid closure....
With side bite Instrument recommended to catch the polypropylene thread in the nose....
Facilitates retrieval of polypropylene guide thread from the nasal cavity when using Ritleng Bicanalicular systems and self threading Monoka systems....
... unique system uses prolene as thread-guide reducing ... The hollow Ritleng Probe is inserted into ... thread-guide is fed through it. The probe ... to pull the silicone tubing in place. ...
Medicine Products: